Ticker,Title,Link
BPMC,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Blueprint Medicines (BPMC), Adaptimmune Therapeutics (ADAP) and Ardelyx (ARDX)",8/7/2024 5:54:04 AM
BPMC,TD Cowen Sticks to Their Buy Rating for Blueprint Medicines (BPMC),8/5/2024 11:17:57 AM
BPMC,Strong Sales and Market Potential Affirm Buy Rating for Blueprint Medicines,8/2/2024 10:26:28 AM
BPMC,Blueprint Medicines: A Strong Buy on Ayvakit’s Success and Promising Pipeline,8/1/2024 9:25:19 PM
BPMC,Blueprint Medicines Q2 2024 Earnings Preview,7/31/2024 4:08:52 PM
BPMC,Barclays Keeps Their Hold Rating on Blueprint Medicines (BPMC),7/29/2024 8:16:38 AM
BPMC,Piper Sandler Keeps Their Hold Rating on Blueprint Medicines (BPMC),7/23/2024 10:39:54 AM
BPMC,Stifel Nicolaus Remains a Buy on Blueprint Medicines (BPMC),7/19/2024 12:16:47 PM
BPMC,Blueprint Medicines (BPMC) Receives a Hold from Morgan Stanley,7/12/2024 12:25:55 PM
BPMC,Expert Ratings For Blueprint Medicines,6/28/2024 3:00:27 PM
BPMC,"Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Arcturus Therapeutics (ARCT) and Blueprint Medicines (BPMC)",6/8/2024 12:40:40 PM
BPMC,Assessing Blueprint Medicines: Insights From 16 Financial Analysts,6/7/2024 8:01:18 PM
BPMC,Wall Street Analysts Are Bullish on Top Healthcare Picks,6/4/2024 1:30:16 PM
BPMC,"Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo",5/25/2024 2:24:03 PM
BPMC,Unveiling 18 Analyst Insights On Blueprint Medicines,5/14/2024 6:00:39 PM
BPMC,Stifel Nicolaus Reaffirms Their Buy Rating on Blueprint Medicines (BPMC),5/9/2024 2:05:25 AM
BPMC,Blueprint Medicines (BPMC) Gets a Hold from Piper Sandler,5/3/2024 12:18:43 PM
BPMC,"BPMC Stock Earnings: Blueprint Medicines Beats EPS, Beats Revenue for Q1 2024",5/2/2024 3:56:57 PM
BPMC,Blueprint Medicines Q1 2024 Earnings Preview,5/1/2024 6:30:27 PM
BPMC,The Analyst Verdict: Blueprint Medicines In The Eyes Of 7 Experts,4/26/2024 2:00:39 PM
BPMC,Piper Sandler Keeps Their Hold Rating on Blueprint Medicines (BPMC),4/22/2024 12:32:06 PM
BPMC,Decoding 6 Analyst Evaluations For Blueprint Medicines,4/10/2024 9:00:35 PM
BPMC,Blueprint Medicines Buy Rating: Promising BLU-222 Efficacy and Strong Financial Outlook,4/9/2024 8:25:19 PM
BPMC,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Blueprint Medicines (BPMC) and Evolent Health (EVH)",4/5/2024 10:40:40 AM
BPMC,"Analysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC), Legend Biotech (LEGN) and Celldex (CLDX)",2/26/2024 11:20:29 AM
BPMC,Stifel Nicolaus Keeps Their Buy Rating on Blueprint Medicines (BPMC),2/23/2024 12:21:10 PM
BPMC,Sell Rating on Blueprint Medicines Amidst Concerns Over Long-Term Growth and Financial Outlook,2/16/2024 12:19:52 PM
BPMC,Blueprint Medicines: A Strong Buy on Surging Ayvakit Sales and Promising Market Expansion,2/15/2024 8:35:30 PM
BPMC,Blueprint Medicines Q4 2023 Earnings Preview,2/14/2024 7:07:39 PM
BPMC,Cracking The Code: Understanding Analyst Reviews For Blueprint Medicines,2/13/2024 4:00:15 PM
BPMC,"Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Arcellx Inc (ACLX)",2/5/2024 1:20:36 PM
BPMC,Investors growing more bullish on SMID cap biotech stocks,2/4/2024 10:16:46 PM
BPMC,"Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Blueprint Medicines (BPMC)",1/17/2024 9:51:01 AM
BPMC,Blueprint Medicines: A Strong Buy on Strategic Focus and Pathway to Profitability,1/11/2024 6:47:16 AM
BPMC,Peeling Back The Layers: Exploring Blueprint Medicines Through Analyst Insights,1/9/2024 4:00:33 PM
BPMC,"Analysts Are Bullish on These Healthcare Stocks: Insmed (INSM), Agilon Health (AGL)",1/8/2024 10:12:16 AM
BPMC,Raymond James Maintains Strong Buy Rating for Blueprint Medicines: Here's What You Need To Know,12/22/2023 6:00:32 PM
BPMC,Buy Blueprint Medicines: Ayvakit’s Market Potential and Positive Physician Feedback Signal Growth,12/21/2023 6:35:34 AM
BPMC,These Biotech Stocks Caught Our Attention - Did You Notice? ,12/16/2023 10:46:38 AM
BPMC,Blueprint Medicines Announces European Commission Approval For AYVAKYT - Quick Facts ,12/12/2023 2:22:40 PM
BPMC,Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session,12/11/2023 7:12:59 PM
BPMC,Blueprint Medicines’ Buoyant Growth Prospects: Ayvakit’s Potential and Robust Pipeline Drive Buy Rating,11/16/2023 12:30:30 PM
BPMC,Oppenheimer Expects the S&P 500’s Advance to Continue Into 2024 — Here’s Why These 2 Stocks Might Be Worth Buying,11/13/2023 9:29:23 PM
BPMC,Blueprint's Ayvakyt Receives Positive CHMP Opinion For Indolent Systemic Mastocytosis Treatment ,11/10/2023 2:54:58 PM
BPMC,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Blueprint Medicines (BPMC), Bioxcel Therapeutics (BTAI) and Aldeyra Therapeutics (ALDX)",11/2/2023 6:02:30 AM
BPMC,Wall Street Analysts Are Bullish on Top Healthcare Picks,10/31/2023 7:01:44 AM
BPMC,Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Blueprint Medicines (BPMC),10/30/2023 2:10:53 AM
BPMC,Needham Maintains Buy Rating for Blueprint Medicines: Here's What You Need To Know,10/27/2023 7:00:36 PM
BPMC,Blueprint Medicines: A Promising Investment with Robust Financial Performance and Innovative Pipeline – A Buy Recommendation by Marc Frahm,10/26/2023 10:45:29 PM
BPMC,Blueprint Medicines earnings: here's what Wall Street expects,10/25/2023 3:01:13 PM
BPMC,"Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board",10/23/2023 2:30:00 PM
BPMC,Berenberg Bank Sticks to Their Buy Rating for Blueprint Medicines (BPMC),9/13/2023 11:35:16 AM
BPMC,Unpacking Blueprint Medicines' Ayvakit's Bright Future: Insights From Latest Physician Survey On Sales Predictions,8/21/2023 9:23:39 PM
BPMC,"Analysts Conflicted on These Healthcare Names: Cellectis SA (CLLS), Globus Medical (GMED) and Blueprint Medicines (BPMC)",8/7/2023 4:30:27 AM
BPMC,"Analysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC), Inari Medical (NARI) and Sarepta Therapeutics (SRPT)",8/4/2023 7:40:29 AM
BPMC,Blueprint Medicines (BPMC) Gets a Buy from H.C. Wainwright,8/3/2023 10:25:10 AM
BPMC,What 15 Analyst Ratings Have To Say About Blueprint Medicines,8/2/2023 8:00:35 PM
BPMC,Blueprint Medicines Q2 2023 Earnings Preview,8/1/2023 5:45:10 PM
BPMC,"Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023",7/31/2023 5:00:47 PM
BPMC,Barclays Keeps Their Hold Rating on Blueprint Medicines (BPMC),7/27/2023 7:55:49 AM
BPMC,Analyst Ratings for Blueprint Medicines,7/14/2023 5:00:48 PM
BPMC,"Analysts Offer Insights on Healthcare Companies: Madrigal Pharmaceuticals (MDGL), Regeneron (REGN) and Blueprint Medicines (BPMC)",7/4/2023 5:30:13 PM
BPMC,Roche pulls thyroid cancer indication for Gavreto,6/30/2023 3:11:20 PM
BPMC,ETF Returns: Mid-Cap Winners And Losers,6/28/2023 10:16:02 PM
BPMC,Analyst Expectations for Blueprint Medicines's Future,6/14/2023 3:01:26 PM
BPMC,3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon,6/12/2023 1:30:39 PM
BPMC,Analysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC) and Relay Therapeutics (RLAY),6/8/2023 4:30:15 AM
BPMC,"Analysts’ Top Healthcare Picks: Akero Therapeutics (AKRO), Blueprint Medicines (BPMC)",6/7/2023 10:30:31 AM
BPMC,Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session,6/5/2023 7:09:09 PM
BPMC,Blueprint Medicines Earns Higher Price Targets Post FDA Approval: Analysts Optimistic on Ayvakit's Future,5/23/2023 9:03:31 PM
BPMC,"Argenx, Blueprint Medicines, Sarepta likely M&A targets - analyst",5/21/2023 1:01:45 PM
BPMC,SVB Securities Keeps Their Hold Rating on Blueprint Medicines (BPMC),5/9/2023 10:55:22 AM
BPMC,Analyst Ratings for Blueprint Medicines,5/5/2023 4:02:11 PM
BPMC,Berenberg Bank Remains a Buy on Blueprint Medicines (BPMC),5/4/2023 5:15:05 PM
BPMC,Blueprint Medicines earnings: here's what Wall Street expects,5/3/2023 3:01:13 PM
BPMC,"Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts",4/29/2023 8:00:00 PM
BPMC,Where Blueprint Medicines Stands With Analysts,4/19/2023 11:01:04 PM
BPMC,16 Analysts Have This to Say About Blueprint Medicines,3/30/2023 6:00:26 PM
BPMC,FDA lifts partial clinical hold on Blueprint Medicine cancer candidate BLU-222,3/28/2023 9:48:21 PM
BPMC,ORIC Pharma gains as H.C. Wainwright upgrades on solid tumor candidate,3/23/2023 12:36:09 PM
BPMC,"Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Danaher (DHR) and Blueprint Medicines (BPMC)",3/21/2023 12:50:48 PM
BPMC,The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector,3/15/2023 3:31:39 PM
BPMC,Wall Street Analysts Are Bullish on Top Healthcare Picks,2/28/2023 11:30:41 AM
BPMC,Blueprint Medicines (BPMC) Receives a Buy from Berenberg Bank,2/27/2023 7:45:05 PM
BPMC,"Blueprint Medicines, Roche end partnership for cancer medicine",2/23/2023 2:11:27 PM
BPMC,Blueprint Medicines (BPMC) Gets a Buy from JMP Securities,2/21/2023 5:35:15 AM
BPMC,SVB Securities Keeps Their Hold Rating on Blueprint Medicines (BPMC),2/17/2023 3:05:30 PM
BPMC,Berenberg Bank Sticks to Its Buy Rating for Blueprint Medicines (BPMC),2/16/2023 7:45:05 PM
BPMC,Notable earnings before Thursday's open,2/15/2023 3:25:44 PM
BPMC,Blueprint Medicines (BPMC) Receives a Buy from Needham,2/14/2023 10:25:06 AM
BPMC,Blueprint Medicines (BPMC) Gets a Buy from JMP Securities,2/10/2023 4:15:07 PM
BPMC,Berenberg Bank Keeps Their Buy Rating on Blueprint Medicines (BPMC),2/9/2023 12:45:07 PM
BPMC,JMP Securities Remains a Buy on Blueprint Medicines (BPMC),2/6/2023 4:25:10 PM
BPMC,Needham Sticks to Their Buy Rating for Blueprint Medicines (BPMC),2/3/2023 5:25:05 PM
BPMC,Analyst Ratings for Blueprint Medicines,1/23/2023 10:00:38 PM
BPMC,Needham Sticks to Their Buy Rating for Blueprint Medicines (BPMC),1/11/2023 11:25:23 AM
BPMC,SVB Securities Reaffirms Their Hold Rating on Blueprint Medicines (BPMC),1/9/2023 4:15:35 AM
BPMC,Needham Keeps Their Buy Rating on Blueprint Medicines (BPMC),1/5/2023 2:55:10 PM
BPMC,Cogent initiated Buy at Needham citing a better profile for cancer candidate,12/14/2022 6:57:49 PM
BPMC,Analysts Offer Insights on Healthcare Companies: Mirati Therapeutics (MRTX) and Blueprint Medicines (BPMC),12/13/2022 4:40:23 PM
BPMC,Where Blueprint Medicines Stands With Analysts,12/12/2022 3:04:22 PM
BPMC,"Analysts Are Bullish on Top Healthcare Stocks: DBV Technologies SA – American (DBVT), Blueprint Medicines (BPMC)",11/4/2022 5:30:42 AM
BPMC,Blueprint cut to Perform at Baird on slow uptake for cancer therapy,11/2/2022 8:04:36 PM
BPMC,"Blueprint Medicines  GAAP EPS of -$2.23 beats by $0.28, revenue of $65.97M beats by $22.09M",11/1/2022 12:40:07 PM
BPMC,Blueprint Medicines is about to announce earnings — here's what Wall Street expects,10/31/2022 3:01:13 PM
BPMC,"Catalyst watch: FOMC jitters, Starbucks and Pfizer earnings, Boeing and AMD events",10/28/2022 6:30:28 PM
BPMC,Blueprint Medicines (BPMC) Gets a Buy from Jefferies,10/26/2022 10:15:12 PM
BPMC,"Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022",9/14/2022 4:07:37 PM
BPMC,Where Blueprint Medicines Stands With Analysts,9/9/2022 3:33:14 PM
BPMC,"ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Blueprint Medicines Corporation Investors to Inquire About Class Action Investigation - BPMC",8/29/2022 10:15:00 PM
BPMC,What 14 Analyst Ratings Have To Say About Blueprint Medicines,8/22/2022 5:12:01 PM
BPMC,"Blueprint Medicines' Ayvakit 'Will Garner Approval' Despite Questions, This Analyst Says",8/18/2022 8:08:55 PM
BPMC,Analyst Sees Deteriorated Treatment Effect Of Blueprint's Much Awaited Mastocytosis Data,8/17/2022 8:56:38 PM
BPMC,Where Blueprint Medicines Stands With Analysts,8/3/2022 9:57:03 PM
BPMC,Blueprint jumps 13% ahead of key data readout despite earnings miss,8/2/2022 2:52:27 PM
BPMC,Blueprint Medicines  Q2 2022 Earnings Preview,8/1/2022 5:06:58 PM
BPMC,3 Biotech Stock Picks From This Wedbush Analyst,7/27/2022 11:29:23 PM
BPMC,Ruth's replaces Dave & Buster's in Raymond James favorites,7/24/2022 10:06:29 PM
BPMC,"Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022",7/8/2022 4:02:55 PM
BPMC,This Analyst Thinks Blueprint Medicines' Non-Dilutive Funding 'Deflates M&A Speculation',6/30/2022 8:35:09 PM
BPMC,What 7 Analyst Ratings Have To Say About Blueprint Medicines,6/27/2022 7:10:06 PM
BPMC,SVB Leerink Maintains Market Perform Rating for Blueprint Medicines: Here's What You Need To Know,6/13/2022 6:24:12 PM
BPMC,44 Stocks Moving In Friday's Mid-Day Session,6/10/2022 6:07:23 PM
BPMC,Blueprint stock falls 9% on swapping goals of Ayvakit trial after FDA directive,6/9/2022 6:17:53 PM
BPMC,"Blueprint Medicines, Mirati, Immunogen gain following Turning Point sale to Bristol Myers (update)",6/3/2022 4:16:56 PM
BPMC,Blueprint raised to Buy at Jefferies on market potential of rare disease therapy,6/1/2022 4:31:39 PM
BPMC,What 3 Analyst Ratings Have To Say About Blueprint Medicines,5/19/2022 5:32:39 PM
BPMC,"ATRC Sees 16-20% Revenue Growth, RIGL On Watch, LUNG Breathes Easy, BPMC Braces For Busy Year ",5/4/2022 11:35:51 AM
BPMC,"The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs",5/3/2022 3:01:06 PM
BPMC,Blueprint Medicines  Q1 2022 Earnings Preview,5/2/2022 4:12:57 PM
BPMC,Where Blueprint Medicines Stands With Analysts,4/13/2022 8:03:10 PM
BPMC,"Blueprint, AstraZeneca ink deal to evaluate combination of lung cancer therapies in ongoing trials",4/8/2022 5:57:55 PM
BPMC,7 Biotech Stocks to Buy With Key Catalysts for April,4/5/2022 10:59:46 AM
BPMC,Blueprint Medicines: EU Approves AYVAKYT For Treatment Of Adults With Advanced Systemic Mastocytosis ,3/25/2022 3:29:16 PM
BPMC,Wednesdays With Wedbush: 3 Smid-Cap Biotech Stock Picks,3/9/2022 6:03:53 PM
BPMC,What 5 Analyst Ratings Have To Say About Blueprint Medicines,3/1/2022 6:31:33 PM
BPMC,"Blueprint, Proteovant forge agreement on protein degrader therapies",2/28/2022 1:58:53 PM
BPMC,"Blueprint Medicines stock down 5% amid analyst downgrades, price target changes",2/17/2022 4:22:38 PM
BPMC,"Blueprint Medicines Slips As Loss Widens In Q4, Missing Estimates ",2/16/2022 4:50:52 PM
BPMC,Blueprint Medicines Q4 2021 Earnings Preview,2/15/2022 4:42:16 PM
BPMC,"The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More",2/13/2022 2:32:29 PM
BPMC,Blueprint Medicines Reports Positive CHMP Opinion To Expand Current Indication For AYVAKYT ,1/28/2022 2:21:17 PM
BPMC,Analyst Ratings For Blueprint Medicines,1/25/2022 7:01:44 PM
BPMC,Blueprint Medicines expects FY21 revenue at high end of $170M-$180M guidance range,1/10/2022 7:16:04 PM
BPMC,50 Biggest Movers From Yesterday,1/6/2022 11:23:01 AM
BPMC,34 Stocks Moving In Wednesday's Mid-Day Session,1/5/2022 6:01:00 PM
BPMC,Blueprint Medicines completes acquisition of Lengo Therapeutics,12/30/2021 2:16:43 PM
BPMC,"Alnylam, Crispr Therapeutics among Goldman's biopharma M&A targets for 2022",12/19/2021 2:00:00 PM
BPMC,Blueprint Medicines grants non-qualified stock options to 13 new employees,12/7/2021 9:08:25 PM
BPMC,Blueprint To Buy Privately Held Lengo For Up To $465 Mln ,11/29/2021 1:41:20 PM
BPMC,Tango Therapeutics names new chief medical officer,11/1/2021 11:15:55 AM
BPMC,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",10/28/2021 2:26:10 PM
BPMC,Notable earnings before Thursday's open,10/27/2021 2:40:31 PM
BPMC,Blueprint Medicines is about to announce its earnings — here's what Wall Street expects,10/26/2021 3:02:03 PM
BPMC,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",10/24/2021 5:45:47 PM
BPMC,Roche Announces Positive CHMP Opinion For Gavreto In RET Fusion-positive Advanced NSCLC ,9/17/2021 1:33:58 PM
BPMC,Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),8/4/2021 10:01:00 PM
BPMC,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",7/29/2021 2:18:48 PM
BPMC,Notable earnings before Thursday's open,7/28/2021 2:01:13 PM
BPMC,"The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More",7/25/2021 3:26:31 PM
BPMC,"Blueprint Medicines to Report Second Quarter 2021 Financial Results on Thursday, July 29, 2021",7/22/2021 2:00:00 PM
BPMC,3 Biotech Stocks Ready for Big Breakthroughs Like Biogen,6/24/2021 7:23:23 PM
BPMC,"The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs",6/20/2021 4:04:37 PM
BPMC,FDA Approves Blueprint Medicines' AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis,6/16/2021 9:50:00 PM
BPMC,"The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs",6/13/2021 6:51:53 PM
BPMC,Seeking Alpha Catalyst Watch,6/11/2021 7:30:02 PM
BPMC,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,6/1/2021 11:31:09 PM
BPMC,Blueprint Medicines names Percy Carter as chief scientific officer,5/17/2021 12:08:40 PM
BPMC,"The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx",4/29/2021 2:15:50 PM
BPMC,Here's what to expect from Blueprint Medicines's earnings,4/27/2021 3:02:23 PM
BPMC,"The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx",4/24/2021 3:24:00 PM
BPMC,Blueprint Medicines reports data from systemic mastocytosis program at AACR 2021,4/12/2021 9:24:49 AM
BPMC,The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight,4/10/2021 3:20:43 PM
BPMC,"Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2021",3/31/2021 4:03:29 PM
BPMC,Blueprint Medicines partner CStone wins Chinese approval for lung cancer therapy,3/24/2021 3:04:42 PM
BPMC,Merck and Pfizer among top picks to lead 2021 biopharma M&A activity: Goldman Sachs,3/12/2021 6:04:49 PM
BPMC,Blueprint says EMA validated Ayvakyt marketing application for systemic mastocytosis,3/3/2021 4:50:01 PM
BPMC,"The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout",2/18/2021 2:14:38 PM
BPMC,Blueprint surges after announcing pipeline progress,2/17/2021 7:14:08 PM
BPMC,Blueprint Medicines Q4 Earnings Preview,2/16/2021 5:08:32 PM
BPMC,Blueprint Medicines earnings: here's what to expect,2/15/2021 3:01:29 PM
BPMC,"The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week",2/14/2021 2:10:15 PM
BPMC,Blueprint Medicines announces leadership transitions,1/11/2021 5:24:48 PM
BPMC,Stocks That Hit 52-Week Highs On Wednesday,12/23/2020 4:57:31 PM
BPMC,Stocks That Hit 52-Week Highs On Friday,12/18/2020 8:42:01 PM
BPMC,Blueprint Medicines files US application for expanded use of Ayvakit,12/17/2020 1:17:26 PM
BPMC,FDA OKs Blueprint Medicines and Roche's Gavreto for type of medullary thyroid cancer,12/1/2020 8:31:05 PM
BPMC,"Blueprint Medicines EPS beats by $1.80, beats on revenue",10/29/2020 11:07:36 AM
BPMC,Blueprint Medicines  Q3 Earnings Preview,10/28/2020 5:49:11 PM
BPMC,Stock Alert: Blueprint Medicines Jumps 10% ,9/22/2020 4:11:02 PM
BPMC,FDA OKs Blueprint's pralsetinib for certain type of lung cancer,9/8/2020 9:01:54 AM
BPMC,"AZN, IQV Team Up To Accelerate COVID-19 Vaccine Work, RIGL's ITP Drug Repurposed, IMV On Watch ",7/15/2020 8:58:10 AM
BPMC,Roche Enters Deal With Blueprint Medicines To Gain Co-development Rights For Pralsetinib ,7/14/2020 7:21:58 AM
BPMC,"LMNL Joins COVID-19 Battle, PFE/BNTX Vaccine Data Promising, EVLO On Watch ",7/2/2020 7:08:19 AM
BPMC,Blueprint Medicines' avapritinib continues to shows effect in mastocytosis study,6/6/2020 2:37:00 PM
BPMC,Deciphera shares halted pending news,5/15/2020 7:25:21 PM
BPMC,"BPMC's VOYAGER Fails, CLSD's NDA Resubmission Faces Delay, SNDX Hits New High ",4/29/2020 6:59:15 AM
BPMC,"NGL, GLOG, OXSQ and CINF among midday movers",4/28/2020 4:42:21 PM
BPMC,Baird's fresh biotech picks have catalysts straight ahead,4/17/2020 6:53:32 PM
BPMC,5 Biotech Stocks to Buy for a Strong Growth Prognosis,3/11/2020 10:10:04 AM
BPMC,Stock To Watch: Blueprint Medicines (BPMC) ,2/12/2020 5:01:08 PM
BPMC,FDA extends action date for Blueprint's avapritinib,2/6/2020 2:19:15 PM
BPMC,"AGTC Catches Eyes, PTLA Bleeds As Antidote Sales Disappoint, RARE Jumps ",1/10/2020 4:06:35 AM
BPMC,REFILE-BRIEF-Blueprint Medicines Expects Decision From European Commission On PDGFRA D842V GIST Indication In Q3 2020,1/9/2020 11:35:09 PM
BPMC,"Top 5 Losers In Healthcare Sector (AGRX, MRUS, BPMC…) ",10/29/2019 5:15:19 AM
BPMC,What Wall Street expects from Blueprint Medicines's earnings,7/30/2019 3:03:13 PM
BPMC,Blueprint Medicines earnings preview: what Wall Street is expecting,5/7/2019 3:03:14 PM
BPMC,"ARDS On The Move, GLPG Reports Positive Data, PRTO Plunges On PATENCY-2 Results ",3/29/2019 6:50:34 AM
BPMC,Here's what Wall Street expects from Blueprint Medicines's earnings,2/24/2019 3:01:31 PM
BPMC,"XLRN On Watch, BPMC Makes An Imprint, Osteoporosis Drug Evenity Faces FDA Panel ",12/3/2018 6:07:04 AM
BPMC,"Week Ahead In Pharmaceuticals: 13 Stocks To Watch (EIDX, NOVN, ZYME...) ",11/10/2018 2:07:49 AM
BPMC,Blueprint Medicines is about to announce its earnings — here's what to expect,10/28/2018 3:02:07 PM
BPMC,"Week Ahead In Pharmaceuticals: 6 Stocks To Watch (BPMC, BHC, ACRX...) ",10/7/2018 3:47:49 AM
BPMC,"ARQL Lifts 2018 Outlook, AXGN Q2 Revenue Up 36%, RXII Catches Eyes ",8/2/2018 9:21:20 AM
BPMC,Blueprint Medicines earnings preview: what to expect,7/30/2018 3:02:46 PM
BPMC,Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity,6/15/2018 2:00:00 PM
BPMC,"An Ear To The Pharma: 8 Stocks To Watch (CMRX, CRBP, KPTI, VRX…) ",6/9/2018 6:45:12 PM
BPMC,"Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Avapritinib, BLU-554 and BLU-667 in Greater China",6/4/2018 1:00:00 PM
BPMC,Blueprint Medicines to Present at Upcoming Investor Conferences in June,5/31/2018 2:00:00 PM
BPMC,Harvard-Incubated Expercoin Protocol to Launch a Network of Decentralized Learning Economies on the Blockchain,5/29/2018 3:00:00 PM
BPMC,Blueprint Medicines Announces Data Presentations at Upcoming ASCO and EHA Meetings Supporting Plans for Rapid Development of Avapritinib in Patients with Gastrointestinal Stromal Tumors and...,5/17/2018 3:00:00 PM
BPMC,BRIEF-Blueprint Medicines Q1 Loss Per Share $1.29,5/2/2018 1:22:17 PM
BPMC,"Blueprint Medicines to Report First Quarter 2018 Financial Results on Wednesday, May 2, 2018",4/25/2018 2:00:00 PM
BPMC,"CLDX Disappoints Investors, ASNS Awaits Data In 2H18, BPMC Fails To Make A Mark ",4/17/2018 6:08:47 AM
BPMC,Blueprint Medicines Publication in Cancer Discovery Highlights Preclinical and Clinical Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667,4/15/2018 3:35:00 PM
BPMC,"An Ear To The Pharma: 9 Stocks To Watch This Week (SELB, AGLE, BPMC, MNOV…) ",4/8/2018 5:02:20 AM
BPMC,Blueprint Medicines to Present Proof-of-Concept Data from Ongoing Phase 1 Clinical Trial of BLU-667 in Patients with RET-Altered Solid Tumors in a Clinical Trials Plenary Session at AACR Annual...,3/14/2018 9:35:00 PM
BPMC,Blueprint Medicines to Present at Cowen and Company 38th Annual Health Care Conference,3/6/2018 2:00:00 PM
BPMC,Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial Results,2/21/2018 1:01:00 PM
BPMC,"Blueprint Medicines to Report Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 21, 2018",2/14/2018 2:00:00 PM
BPMC,"ADRO Dumps CRS-207, Another Win For CoolSculpting, FDA Expands GSK's Nucala Use ",12/13/2017 8:38:37 AM
BPMC,"ARGX Soars, SNSS Catches Eyes, BPMC, BLUE Turn Heads, FDA Nod For SNNA ",12/12/2017 3:35:47 AM
BPMC,"Watch Out For BLUE, BPMC, GBT, KURA, KDMN, SYRS Today ",12/11/2017 5:30:50 AM
BPMC,Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of Avapritinib (BLU-285) in Patients with Advanced Systemic Mastocytosis Showing Evidence of Strong Clinical Activity,12/10/2017 2:00:00 PM
BPMC,"ASH: BPMC To Make A Mark; FATE So Far, So Good; Watch Out For SYRS, BIVV ",12/5/2017 1:04:33 PM
BPMC,"Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors",11/30/2017 12:50:00 PM
BPMC,Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors Showing Strengthened Clinical Activity across...,11/10/2017 3:00:00 PM
BPMC,Blueprint Medicines to Present at Jefferies Global Healthcare Conference,11/8/2017 10:01:00 PM
BPMC,ABUS Is Abuzz... ,11/3/2017 10:34:15 AM
BPMC,"Busy Year Awaits FLKS, Mark Your Calendar For BPMC Data, CLLS Loses Steam ",11/2/2017 3:37:40 AM
BPMC,Blueprint Medicines Announces Publication of BLU-285 Translational Data,11/1/2017 9:01:00 PM
BPMC,Blueprint Medicines Reports Third Quarter 2017 Financial Results,10/31/2017 12:00:00 PM
BPMC,"Blueprint Medicines to Report Third Quarter 2017 Financial Results on Tuesday, October 31, 2017",10/24/2017 2:00:00 PM
BPMC,"Blueprint Medicines Announces Appointment of Christopher Murray, Ph.D. as Senior Vice President, Technical Operations",10/10/2017 10:01:00 PM
BPMC,"TTOO Catches Investors' Eyes, SIEN Shaping Up, AGTC Slips Into Red ",9/14/2017 4:21:49 AM
BPMC,"New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch ",9/11/2017 6:58:22 AM
BPMC,Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma,9/10/2017 4:30:00 PM
BPMC,Blueprint Medicines to Present at Morgan Stanley 15th Annual Global Healthcare Conference,9/6/2017 2:00:00 PM
BPMC,"Gainers & Losers Of Aug.22: OVID, SNNA, BPMC, ABIO, TOCA... ",8/23/2017 4:41:57 AM
BPMC,"FDA Approves IRWD's Gout Drug, It's A Thumbs Up For ALXN In EU, CRME Crushed ",8/22/2017 7:35:03 AM
BPMC,Blueprint Medicines to Present Updated Data from Ongoing Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma at ESMO 2017 Congress and 11th ILCA Annual Conference,8/21/2017 10:30:00 PM
BPMC,"Stock Performance Review on Biotech Industry -- Blueprint Medicines, Calithera Biosciences, Concordia Intl., and Cytokinetics",8/14/2017 1:10:00 PM
BPMC,Blueprint Medicines to Present at Upcoming Investor Conferences in August,8/3/2017 2:00:00 PM
BPMC,Blueprint Medicines Reports Second Quarter 2017 Financial Results,8/2/2017 1:00:00 PM
BPMC,"Blueprint Medicines to Report Second Quarter 2017 Financial Results on Wednesday, August 2, 2017",7/26/2017 2:00:00 PM
BPMC,"Gainers & Losers Of July 5: CALA, NVRO, BPMC, KMPH, FLDM... ",7/6/2017 4:05:07 AM
BPMC,Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to Pursue Expedited Development in Patients with a PDGFRα D842V Mutation,6/5/2017 2:00:00 PM
BPMC,"SNDX Rises On Entinostat Data, Kalydeco Gets FDA Nod, Concert Fails To Enthrall ",5/18/2017 8:22:28 AM
BPMC,Blueprint Medicines Reports First Quarter 2017 Financial Results,5/3/2017 1:00:00 PM
BPMC,"Blueprint Medicines to Report First Quarter 2017 Financial Results on Wednesday, May 3, 2017",4/26/2017 2:00:00 PM
BPMC,Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock,4/4/2017 10:01:00 PM
BPMC,Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock,3/30/2017 12:55:00 AM
BPMC,Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock,3/29/2017 1:30:00 PM
BPMC,Blueprint Medicines to Present on BLU-285 and BLU-554 at Upcoming Scientific Conferences,3/27/2017 10:01:00 PM
BPMC,Blueprint Medicines Announces Enrollment of First Patient in Phase 1 Clinical Trial for BLU-667,3/20/2017 9:01:00 PM
BPMC,Blueprint Medicines Reports Fourth Quarter and Full Year 2016 Financial Results,3/9/2017 1:00:00 PM
BPMC,"Blueprint Medicines to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, March 9, 2017",3/2/2017 2:00:00 PM
BPMC,Blueprint Medicines to Present at Upcoming Investor Conferences in March,2/28/2017 2:00:00 PM
